论文部分内容阅读
目的分析研究联合采用双黄连口服液以及利巴韦林注射液对流行性感冒产生的临床疗效。方法抽取我院收治的86例患有流行性感冒的病人作为研究对象,将其随机均分为观察组和对照组,对照组单纯给予利巴韦林注射液进行治疗,观察组联合给予双黄连口服液以及利巴韦林注射液进行治疗,对比两组临床疗效。结果观察组治疗总有效率97.7%,明显高于对照组81.4%,差异显著(x2=6.081,P<0.05)。结论联合采用双黄连口服液以及利巴韦林注射液对流行性感冒进行治疗,可以获得显著疗效,同时没有明显不良反应,具有较高应用价值。
Objective To study the clinical efficacy of combined Shuanghuanglian oral liquid and ribavirin injection on influenza. Methods Totally 86 patients with influenza in our hospital were selected as the research object and randomly divided into observation group and control group. The control group was treated with ribavirin injection only. The observation group was given Shuanghuanglian Oral solution and ribavirin injection for treatment, comparing the clinical efficacy of two groups. Results The total effective rate of observation group was 97.7%, which was significantly higher than that of control group (81.4%) (x2 = 6.081, P <0.05). Conclusions The combination of Shuanghuanglian oral liquid and ribavirin injection for the treatment of influenza can achieve significant curative effect with no obvious side effects and high application value.